EssilorLuxottica/€EL

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About EssilorLuxottica

EssilorLuxottica is a French-Italian multinational corporation operating in the eyewear and eye care industry. It was formed through the merger of the French ophthalmic optics company Essilor and the Italian eyewear company Luxottica in 2018. The company designs, manufactures, and distributes ophthalmic lenses, optical equipment, and eyewear, including well-known brands such as Ray-Ban, Oakley, and Persol, as well as licensed brands like Chanel and Prada. Headquartered in Charenton-le-Pont, France, and Milan, Italy, EssilorLuxottica has a global presence with operations in over 150 countries. Its strategic positioning is underscored by its integrated business model that encompasses both retail and wholesale distribution, leveraging its extensive portfolio of proprietary and licensed brands.

Ticker

€EL
Sector

Primary listing

PAR

Employees

200,076

EssilorLuxottica Metrics

BasicAdvanced
€129B
54.08
€5.15
0.75
€3.95
1.42%

What the Analysts think about EssilorLuxottica

Analyst ratings (Buy, Hold, Sell) for EssilorLuxottica stock.

Bulls say / Bears say

EssilorLuxottica’s first-half 2025 revenue rose 7.3% at constant exchange rates, driven by solid growth across both Professional Solutions and Direct-to-Consumer segments (Reuters)
Sales of Ray-Ban Meta smart glasses more than tripled year-over-year in H1 2025, evidencing strong market adoption of its AI-powered eyewear platform and bolstering its position in the wearable tech market (Reuters)
The announced acquisition of Optegra eyecare clinics expands EssilorLuxottica’s footprint into surgical and diagnostic ophthalmic services, enhancing its integrated eyecare model and diversifying revenue streams (Reuters)
To manage new U.S. import duties of up to 145% on China-made products and 36% on Thailand-made goods, EssilorLuxottica plans single-digit price increases in the U.S., risking volume contraction in its largest market (Reuters)
First-half adjusted operating profit increased only 4.1% to €2.53 billion, slightly below analyst expectations of €2.55 billion, reflecting margin pressure from tariffs and a weaker dollar (Reuters)
Although recent U.S. antitrust suits were dismissed, EssilorLuxottica remains under scrutiny for its market dominance, with the potential for renewed legal challenges or regulation in other jurisdictions that could raise compliance costs (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 9 Oct 2025.

EssilorLuxottica Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

EssilorLuxottica Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €EL

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs